Authors:
Ishioka, GY
Fikes, J
Qin, MS
Gianfrani, C
Chesnut, RW
Kahn, LE
Streeter, PR
Woulfe, SL
Sette, A
Citation: Gy. Ishioka et al., Dendritic cells generated in vivo by a chimeric hematopoietic growth factor, progenipoietin-4, demonstrate potent immunological function, VACCINE, 19(27), 2001, pp. 3710-3719
Authors:
Tangri, S
Ishioka, GY
Huang, XQ
Sidney, J
Southwood, S
Fikes, S
Sette, A
Citation: S. Tangri et al., Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide, J EXP MED, 194(6), 2001, pp. 833-846
Authors:
Tsunoda, I
Sette, A
Fujinami, RS
Oseroff, C
Ruppert, J
Dahlberg, C
Southwood, S
Arrhenius, T
Kuang, LQ
Kubo, RT
Chesnut, RW
Ishioka, GY
Citation: I. Tsunoda et al., Lipopeptide particles as the immunologically active component of CTL inducing vaccines, VACCINE, 17(7-8), 1999, pp. 675-685
Authors:
Ishioka, GY
Fikes, J
Hermanson, G
Livingston, B
Crimi, C
Qin, MS
del Guercio, MF
Oseroff, C
Dahlberg, C
Alexander, J
Chesnut, RW
Sette, A
Citation: Gy. Ishioka et al., Utilization of MHC class I transgenic mice for development of minigene DNAvaccines encoding multiple HLA-restricted CTL epitopes, J IMMUNOL, 162(7), 1999, pp. 3915-3925